Arabic Arabic English English French French German German
dark

New subcutaneous formulation of Tysabri approved in UK

Multiple sclerosis treatment can now be administered subcutaneously or intravenously Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

EMA begins review of GSK/Vir’s COVID-19 antibody

Next Post

Media briefing on COVID-19

Related Posts
Total
0
Share